Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

AXIM Relative to the S&P 500

AXIM Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the AXIM Biotechnologies Inc. (OTCMKT:AXIM) seasonal charts above shows that a Buy Date of March 13 and a Sell Date of July 2 has resulted in a geometric average return of 34.28% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 57.97% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

AXIM Biotechnologies, Inc. operates as a biotechnology company, which engages in the development of diagnostic healthcare solutions. Its product categories include Eye Health, SARS-CoV-2, and fentanyl neutralizing antibody test. The company was founded on November 18, 2010 and is headquartered in San Diego, CA.

To download AXIM seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: AXIM